ArticleFrontiers in immunology2024

An antigen-specific immunotherapeutic, AKS-107, deletes insulin-specific B cells and prevents murine autoimmune diabetes.

David G Alleva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.